Home » Stocks » ARAY

Accuray Incorporated (ARAY)

Stock Price: $4.19 USD 0.03 (0.72%)
Updated Jul 23, 2021 4:00 PM EDT - Market closed
Market Cap 377.77M
Revenue (ttm) 380.33M
Net Income (ttm) 4.63M
Shares Out 93.12M
EPS (ttm) 0.05
PE Ratio 83.80
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $4.19
Previous Close $4.16
Change ($) 0.03
Change (%) 0.72%
Day's Open 4.15
Day's Range 4.13 - 4.21
Day's Volume 221,481
52-Week Range 2.17 - 6.02

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

SUNNYVALE, Calif., July 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at Hong Kong Sanatorium & Hospital (HKSH) in Hong Kong treated the first c...

2 days ago - PRNewsWire

SUNNYVALE, Calif., July 14, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2021, ended June 30, 2021, after the market clos...

1 week ago - PRNewsWire

SUNNYVALE, Calif., June 24, 2021 /PRNewswire/ -- The University of Wisconsin-Madison (UW-Madison) School of Veterinary Medicine team is advancing cancer care as the first to treat an animal using the Ra...

1 month ago - PRNewsWire

SUNNYVALE, Calif., June 22, 2021 /PRNewswire/ -- Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021.

1 month ago - PRNewsWire

Accuray (ARAY) introduces RayStation treatment planning support for CyberKnife Radiotherapy System and other radiation therapy devices.

1 month ago - Zacks Investment Research

SUNNYVALE, Calif., June 16, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7™** Ro...

1 month ago - PRNewsWire

Accuray's (ARAY) ClearRT imaging capability, which is now widely available following receipt of the CE Mark, offers better precision and accuracy in radiation therapy.

1 month ago - Zacks Investment Research

SUNNYVALE, Calif., June 10, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT™ helical fan-beam kVCT imaging capabil...

1 month ago - PRNewsWire

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

Investors continue to be optimistic about Accuray (ARAY) owing to its slew of regulatory approvals and strength in its TomoTherapy platform.

1 month ago - Zacks Investment Research

SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving credit facility wit...

2 months ago - PRNewsWire

SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior ...

2 months ago - PRNewsWire

SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Jean-Philippe Pignol, M.D.

2 months ago - PRNewsWire

ARAY, EBS, FARM, SHLX, and TPB have been added to the Zacks Rank #5 (Strong Sell) List on April 30, 2021

Other stocks mentioned: EBS, FARM, SHLX, TPB
2 months ago - Zacks Investment Research

SUNNYVALE, Calif., April 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Accuray customers took the top two positions in the MArkerless Lung Target Tracking CHallenge (...

2 months ago - PRNewsWire

Accuray (ARAY) registers growth in Service and Product revenues during fiscal Q3.

2 months ago - Zacks Investment Research

Accuray (ARAY) delivered earnings and revenue surprises of -100.00% and 2.97%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

SUNNYVALE, Calif., April 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2021 ended March 31, 2021.

2 months ago - PRNewsWire

SUNNYVALE, Calif., April 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the innovative ClearRT™ helical fan-beam kVCT imaging* capability has now been in clinical use ...

3 months ago - PRNewsWire

SUNNYVALE, Calif., April 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2021, ended March 31, 2021, after the market clos...

3 months ago - PRNewsWire

SUNNYVALE, Calif., Feb. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the Cowen Annual Health Care Conference. The management team is scheduled to par...

5 months ago - PRNewsWire

SUNNYVALE, Calif., Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott, M.D., MBA to the company's Board of Directors, effective as of Feb...

5 months ago - PRNewsWire

SUNNYVALE, Calif., Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Confere...

5 months ago - PRNewsWire

Accuray announced better than expected fiscal Q2 results, with the first revenue from its China Type A license backlog. Orders remain erratic, but the backlog was up 11% yoy and stable sequentially, and...

5 months ago - Seeking Alpha

Accuray (ARAY) registers growth in Service revenues during fiscal Q2.

5 months ago - Zacks Investment Research

Accuray Incorporated (ARAY) CEO Josh Levine on Q2 2021 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Accuray (ARAY) delivered earnings and revenue surprises of 600.00% and 4.96%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

SUNNYVALE, Calif., Jan. 27, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2021 ended December 31, 2020. Second Quarter Fi...

5 months ago - PRNewsWire

One of the counterintuitive dynamics of the pandemic-disrupted year in 2020 was the rise of Wall Street. But that doesn't mean you've missed the boat, as these stocks under $10 demonstrate.

Other stocks mentioned: CAN, GPRO, KGC, LKYSF, MAGS, MZDAY, OPTT ...
5 months ago - InvestorPlace

Accuray (ARAY) releases positive data from a prospective trial of 338 women with low-risk breast cancer.

5 months ago - Zacks Investment Research

SUNNYVALE, Calif., Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8 per...

6 months ago - PRNewsWire

SUNNYVALE, Calif., Jan. 8, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the market cl...

6 months ago - PRNewsWire

Accuray (ARAY) new innovative imaging solution is designed to provide cost effective and exceptional diagnostic quality image.

6 months ago - Zacks Investment Research

SUNNYVALE, Calif., Jan. 6, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in the 39th J.P. Morgan Annual Healthcare Conference. Josh Levine, President and CEO...

6 months ago - PRNewsWire

SUNNYVALE, Calif., Jan. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for it...

6 months ago - PRNewsWire

This year has been a remarkable one for cheap stocks, many of which have enjoyed contrarian upside. However, there are still more opportunities to be had for the intrepid speculator.

Other stocks mentioned: ABEV, ADT, AIV, DL, F, HVBTF, TK
6 months ago - InvestorPlace

Accuray (ARAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

6 months ago - Zacks Investment Research

Investor confidence is high on Accuray (ARAY) stock, courtesy of its solid prospects.

6 months ago - Zacks Investment Research

SUNNYVALE, Calif., Dec. 3, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Jim Dennison, the company's new ...

7 months ago - PRNewsWire

Does Accuray (ARAY) have what it takes to be a top stock pick for momentum investors? Let's find out.

8 months ago - Zacks Investment Research

Accuray's (ARAY) new deal with DHL Supply Chain will help in the delivery of advanced cancer treatment technology.

8 months ago - Zacks Investment Research

SUNNYVALE, Calif. and WESTERVILLE, Ohio, Nov. 18, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and DHL Supply Chain announced today they have entered into a global service parts logistics pa...

8 months ago - PRNewsWire

SUNNYVALE, Calif., Nov. 12, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Jim Dennison as its senior vice president of global quality and regulatory affairs, ...

8 months ago - PRNewsWire

SUNNYVALE, Calif., Nov. 10, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that innovations in hardware and software solutions and clinical data presented at this year's ASTRO ...

8 months ago - PRNewsWire

LONDON--(BUSINESS WIRE)-- #GlobalHeadandNeckCancerDiagnosticsMarket--The Head and Neck Cancer Diagnostics Market will grow by USD 3.41 bn during 2020-2024

Other stocks mentioned: CAJ
8 months ago - Business Wire

Accuray (ARAY) registered growth in Service revenues in Q1.

8 months ago - Zacks Investment Research

Fiscal first quarter revenue was a little better than expected, and management did well on costs, achieving a modest profit where a modest loss had been expected. Orders were down, not surprising given ...

8 months ago - Seeking Alpha

Accuray Incorporated (ARAY) CEO Josh Levine on Q1 2021 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Accuray (ARAY) delivered earnings and revenue surprises of 100.00% and 10.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

About ARAY

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during ... [Read more...]

Industry
Medical Devices
IPO Date
Feb 8, 2007
CEO
Joshua Levine
Employees
932
Stock Exchange
NASDAQ
Ticker Symbol
ARAY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Accuray stock is "Strong Buy." The 12-month stock price forecast is 8.25, which is an increase of 96.90% from the latest price.

Price Target
$8.25
(96.90% upside)
Analyst Consensus: Strong Buy